CollPlant Biotechnologies (CLGN) Beginning Cash Balance (2023 - 2024)
CollPlant Biotechnologies (CLGN) reported Beginning Cash Balance of $26.7 million for Q1 2024, down 10.68% on a YoY basis from $29.9 million in Q2 2023, and up 12741.71% quarter-over-quarter from -$211000.0 in Q2 2023.
CollPlant Biotechnologies (CLGN) Beginning Cash Balance (2023 - 2024) Analysis & Trends
CollPlant Biotechnologies has reported Beginning Cash Balance for 2 years, with the latest figure at $26.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 26.67 Mn |
| Mar 31, 2024 | 26.67 Mn |
| Jun 30, 2023 | -211,000.00 |
| Jun 30, 2023 | -211,000.00 |
| Mar 31, 2023 | 29.86 Mn |
| Mar 31, 2023 | 29.86 Mn |